Levamisole-induced attenuation of alveolar macrophage dysfunction in respiratory virus-infected calves
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (4) , 377-385
- https://doi.org/10.1016/0192-0561(88)90124-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Toxicological Aspects of Alterations of Pulmonary Macrophage FunctionAnnual Review of Pharmacology and Toxicology, 1986
- The modulation of peritoneal macrophage chemiluminescence by acute pleural inflammation, prostanoids and cyclo/lipoxygenase inhibitorsInflammation Research, 1985
- In vitro determination of phagocyte activity by luminol- and lucigenin-amplified chemiluminescenceInternational Journal of Immunopharmacology, 1984
- Macrophage signal recognitionInflammation Research, 1984
- Reactive oxygen production, arachidonate metabolism and cyclic AMP in macrophagesBiochemical and Biophysical Research Communications, 1983
- Modulation of macrophage superoxide release by purine metabolismLife Sciences, 1983
- Effect of levamisole on lysosomal enzyme release from polymorphonuclear leukocytes and intracellular levels of cAMP and cGMP after phagocytosis of monosodium urate crystalsInflammation Research, 1980
- Protective effect of levamisole and its sulfhydryl metabolite OMPI against cell death induced by glutathione depletionInternational Journal of Immunopharmacology, 1979
- The effects of levamisole on some functions of mouse macrophages after in vitro and in vivo administrationInternational Journal of Immunopharmacology, 1979
- Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activityBiochemical and Biophysical Research Communications, 1972